Moderna’s RSV shot 83.7% effective, late-stage trial shows
By Paige Twentier for Becker’s Hospital Review on January 18, 2023 Moderna’s respiratory syncytial virus vaccine candidate for older adults
Read moreA trusted source for Medicare news and education from the AMAC Foundation.
By Paige Twentier for Becker’s Hospital Review on January 18, 2023 Moderna’s respiratory syncytial virus vaccine candidate for older adults
Read moreBy Judith Graham on January 18, 2023 for Kaiser Health News A new coronavirus variant is circulating, the most transmissible
Read moreBy Kaitlyn Radde on January 17, 2023 for NPR Socially isolated older adults have a 27% higher chance of developing
Read more(By Christina Saint Louis for Kaiser Health News) MALMO, Minn. — Eight women, all 73 or older, paced the fellowship
Read more(By Judith Graham for Kaiser Health News) Larry McMahon, who turns 80 this month, is weighing whether to undergo a
Read moreBy Bari Faye Dean for Becker’s Hospital Review on December 28, 2022 Research scientists at the University of Pittsburgh School
Read moreBy Mariah Taylor for Becker’s Hospital Review on December 28, 2022 The American Heart Association released a new scientific statement
Read moreBy Erica Carbajal for Becker’s Hospital Review on December 27, 2022 About three years into the COVID-19 pandemic, and the
Read moreBy Selena Simmons-Duffin for NPR on December 28, 2022 The U.S. has come a long way from two years ago
Read moreBy Mackenzie Bean for Becker’s Hospital Review on December 22, 2022 The 2022-2023 flu season is well underway, with the
Read more